Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-03-000434
Filing Date
2003-02-14
Accepted
2003-02-14 12:06:33
Documents
3
Group Members
ORBIMED ADVISORS INC.ORBIMED ADVISORS LLCORBIMED CAPITAL LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A sc13ga_021203-biotech.txt SC 13G/A 9932
3 JOINT FILING AGREEMENT ex1-1_021203biotech.txt EX-1.1 2435
4 STATEMENT OF CONTROL PERSON ex2-1_021203biotech.txt EX-2.1 942
  Complete submission text file 0000947871-03-000434.txt   15541
Mailing Address 70 WOOD AVENUE SOUTH ISELIN NJ 08830
Business Address 70 WOOD AVE S ISELIN NJ 08830 9086328800
BIO TECHNOLOGY GENERAL CORP (Subject) CIK: 0000722104 (see all company filings)

EIN.: 133033811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-34455 | Film No.: 03564399
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address
Business Address 41 MADISON AVE 40TH FL NEW YORK NY 10010 2126845700
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE